Chronic Hepatitis C Virus Treatment Market

Hepatitis C is a liver disease which is caused by the hepatitis C virus. Hepatitis C virus can cause both acute as well as chronic hepatitis. The hepatitis C virus is a common bloodborne virus and the most common modes of infection are by the exposure to small quantities of blood.The infection can occur through unsafe injection practices, transfusion of unscreened blood and blood products and unsafe health care .The reuse and inadequate sterilization of needles and other medical equipment and the transfusion od blood products can cause chronic hepatitis c virus. The symptoms of hepatitis c virus infection includes jaundice , stomach pain , Nausea , Fatigue etc which need to be observed for the chronic hepatitis c virus treatment . Globally, an estimated 71 million people have chronic hepatitis C infection. A significant number of those who are chronically infected with hepatitis c virus have more chances to develop cirrhosis or liver cancer. Approximately 399 000 people die each year from hepatitis C, mostly from hepatocellular carcinoma and cirrhosis. Antiviral medicines such as pegylated interferon, Ribavirin, Simeprevir can reduce the risk of death from liver cancer and play a major role in chronic hepatitis c virus treatment. Chronic Hepatitis C virus infection can be transmitted sexually and can be passed from mother to her baby but these modes of transmission are not so common.